SlideShare a Scribd company logo
1 of 6
Download to read offline
Holiday discount, 50% off!
                December 1st 2011 - January 15th 2012

We announce our holiday discount!

In the period between December 1st 2011 and January 15th 2012 we offer 50% off on
the following products.

Get your free trial or demo versions now, try them, and order your licenses during the
discount period!




geneXplain Platform
The geneXplain platform is an online toolbox and workflow management system for scientists in the
field of molecular biology. Here, you can store and analyze your experimental data - including
transcriptomics, proteomics, and ChIP-Seq -, search for master regulator molecules, perform gene set
enrichment analysis, and even add your own workflows and scripts.

Key features of the platform:

      Collection, storage and analysis of experimental data
      Loading raw microarray data, BED files and more
      Statistical processing of raw data
      Comfortable work with tabulated data: comparison, joining, subtracting, sorting, etc.
      Mapping to Gene Ontology terms, Gene Set Enrichment Analysis
      Network clustering and search for master regulator molecules, visualization of pathway
       diagrams in several different layouts, export in a number of formats
      Dynamic simulations
      Browsing through several databases
      Possibility to graphically program a specific pipeline (workflow), and add new scripts

The geneXplain platform combines a growing number of analytical modules (bricks) under a
standardized interface, which can be flexibly combined to comprehensive workflows via a simple drag-
and-drop system. Predefined workflows are already available, as well as state-of-the-art bricks. Also,
the scientific community is invited to add their own bricks as scripts or plug-ins into the platform.




A fully functional free trial account, as well as further information, is available on our homepage:
http://www.genexplain.com/genexplain-platform
IMC
In-silico molecular cloning (IMC) is a renowned software package for comprehensive analysis,
annotation and visualization of genomic features. It has been on the Japanese market for over six
years and is now being distributed internationally.

Key features of IMC:

      Drawing of plasmid maps
      DNA digestion by restriction enzymes
      Ligation of sequences
      PCR, from primer design to gel electrophoresis of the results
      Amino acid profile analysis
      Automatic or manual annotation of features
      Search for homologies, patterns and repeats
      Array analysis

The IMC software package provides a rich functionality; methods from in silico molecular cloning to
genome to array analysis are included in the IMC Array edition (IMC-AE). The IMC Genomics edition
(IMC-GE) focuses on functions to handle genome data, the standard edition (IMC-SE) provides all basic
functions to visualize genomic annotation.

The software runs on Windows, Mac and Linux and has been developed by in silico biology, Inc., in
Yokohama, Japan (http://www.insilicobiology.jp/en).




A free fully functional trial version, as well as further information, is available on our homepage:
http://www.genexplain.com/imc
GenomeTraveler
GenomeTraveler (GT) is a comprehensive software package for the analysis of whole genomes, which
supports mapping of NGS fragments, mutation analysis, feature annotation and more.

Key features of GenomeTraveler:

      Mapping of single- and paired-end fragments
      Contig mapping
      de novo assembly
      Import of mapping/assembling results from SAMtool, SOLiD, Velvet and Phrab
      Profile peak detection
      Mutation and SNP analysis
      Expression analysis
      The alignment viewer includes: search, annotation and comparative genome functions

GenomeTraveler is a program for next generation sequencing data analysis and annotation. It can
handle data from Roche/454 GS FLX, ABI SOLiD and Illumina GA, and provides a graphical interface
for smooth viewing and editing of mapping and assembly results.

The software runs on Windows, Mac and Linux and has been developed by in silico biology, Inc., in
Yokohama, Japan (http://www.insilicobiology.jp/en).




A free fully functional trial version, as well as further information, is available on our homepage:
http://www.genexplain.com/genome-traveler
PASS
The acronym PASS stands for Prediction of Activity Spectra for Substances. After entering structural
formulas of drug-like organic compounds - either a single structure or a big library - the program
instantly gives a list of predicted bioactivities, accompanied by estimated mathematical probabilities.

Key features of PASS:

      Standard MOL and SDF files are used as input structural data
      Multilevel Neighborhood of Atoms (MNA) descriptors are used to create robust and predictive
       SAR models
      Activity spectra for thousands of compounds can be predicted within minutes
      Impact of each atom on a particular activity is highlighted by its color
      Currently, over 4,300 bioactivities can be predicted
      Mathematical algorithm based on Bayesian estimates of probabilities

PASS can quickly predict biological activity spectra for organic drug-like compounds qualitatively. The
activities that can be predicted range from pharmacotherapeutic effects, biochemical mechanisms and
toxic and adverse effects to influence on the metabolism, gene regulation and transporter-related
activities. The software runs under Windows.

Since more than 15 years, PASS is permanently being developed by Vladimir Poroikov, Dmitry
Filimonov & Associates currently working in the Department for Bioinformatics at the Institute of
Biomedical    Chemistry,     Russian    Academy     of    Medical     Sciences     in    Moscow
(http://www.pharmaexpert.ru/PASSOnline/).




A free demo version, as well           as   further   information,   is   available   on   our   website:
http://www.genexplain.com/pass
PharmaExpert
PharmaExpert analyzes the relationships between biological activities, drug-drug interactions and the
multiple targeting actions of chemical compounds. As a pharmacological knowledge-based tool, it
provides in silico screening of compounds using PASS prediction results.

Key features of PharmaExpert:

      Mechanism-effect relationship (MER) base, manually curated by experts, containing 11,049
       mechanism-effect relationships
      Selection of compounds with required therapeutic but without side effects
      Comparative analysis of compounds with similar structures
      Selection of compounds with multiple mechanisms of action
      Analysis of drug-drug interactions with regard to their pharmacokinetic, pharmacodynamic and
       adverse effects

PharmaExpert uses PASS (Prediction of Activity Spectra for Substances) predictions as input
information. It provides a comfortable solution for data mining of the PASS prediction results to find
the best drug-like candidates from a set of compounds. The core of the program is a mechanism-effect
relationship (MER) base, which is used to determine cause-effect relationships for the compounds. Like
PASS, the software runs under Windows.

Since more than 15 years, PharmaExpert is permanently being developed by Vladimir Poroikov, Dmitry
Filimonov & Associates currently working in the Department for Bioinformatics at the Institute of
Biomedical    Chemistry,     Russian     Academy     of     Medical    Sciences     in     Moscow
(http://www.pharmaexpert.ru/PASSOnline/).




A free demo version, as well as further            information,   is   available   on   our   homepage:
http://www.genexplain.com/pharmaexpert
About geneXplain GmbH
GeneXplain GmbH has been founded in April 2010 and is based in Wolfenbüttel, Germany. The
company aims at providing a comprehensive set of computational tools supporting the complete drug
development pipeline from the statistical evaluation of high-throughput data, their biological
interpretation, and identification of potential targets to the prediction of most promising lead
structures. The geneXplain platform is based on BioUML and has been developed together with the
Institute of Systems Biology, Novosibirsk, Russia, where this leading-edge technology originates.




Your geneXplain team


geneXplain GmbH
Am Exer 10b
D-38302 Wolfenbüttel
Germany

phone: +49-5331-9450434
e-mail: info@genexplain.com

URL: http://www.genexplain.com
Facebook: http://www.facebook.com/genexplain
Twitter: https://twitter.com/#!/geneXplain
LinkedIn: http://www.linkedin.com/company/genexplain
Google+: https://plus.google.com/104816244332282237960

More Related Content

Recently uploaded

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
panagenda
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 

Recently uploaded (20)

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024Manulife - Insurer Transformation Award 2024
Manulife - Insurer Transformation Award 2024
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 

Featured

How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
ThinkNow
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Kurio // The Social Media Age(ncy)
 

Featured (20)

How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
 
Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
 
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
 
ChatGPT webinar slides
ChatGPT webinar slidesChatGPT webinar slides
ChatGPT webinar slides
 

Holiday Discount 2011 -50% off!

  • 1. Holiday discount, 50% off! December 1st 2011 - January 15th 2012 We announce our holiday discount! In the period between December 1st 2011 and January 15th 2012 we offer 50% off on the following products. Get your free trial or demo versions now, try them, and order your licenses during the discount period! geneXplain Platform The geneXplain platform is an online toolbox and workflow management system for scientists in the field of molecular biology. Here, you can store and analyze your experimental data - including transcriptomics, proteomics, and ChIP-Seq -, search for master regulator molecules, perform gene set enrichment analysis, and even add your own workflows and scripts. Key features of the platform:  Collection, storage and analysis of experimental data  Loading raw microarray data, BED files and more  Statistical processing of raw data  Comfortable work with tabulated data: comparison, joining, subtracting, sorting, etc.  Mapping to Gene Ontology terms, Gene Set Enrichment Analysis  Network clustering and search for master regulator molecules, visualization of pathway diagrams in several different layouts, export in a number of formats  Dynamic simulations  Browsing through several databases  Possibility to graphically program a specific pipeline (workflow), and add new scripts The geneXplain platform combines a growing number of analytical modules (bricks) under a standardized interface, which can be flexibly combined to comprehensive workflows via a simple drag- and-drop system. Predefined workflows are already available, as well as state-of-the-art bricks. Also, the scientific community is invited to add their own bricks as scripts or plug-ins into the platform. A fully functional free trial account, as well as further information, is available on our homepage: http://www.genexplain.com/genexplain-platform
  • 2. IMC In-silico molecular cloning (IMC) is a renowned software package for comprehensive analysis, annotation and visualization of genomic features. It has been on the Japanese market for over six years and is now being distributed internationally. Key features of IMC:  Drawing of plasmid maps  DNA digestion by restriction enzymes  Ligation of sequences  PCR, from primer design to gel electrophoresis of the results  Amino acid profile analysis  Automatic or manual annotation of features  Search for homologies, patterns and repeats  Array analysis The IMC software package provides a rich functionality; methods from in silico molecular cloning to genome to array analysis are included in the IMC Array edition (IMC-AE). The IMC Genomics edition (IMC-GE) focuses on functions to handle genome data, the standard edition (IMC-SE) provides all basic functions to visualize genomic annotation. The software runs on Windows, Mac and Linux and has been developed by in silico biology, Inc., in Yokohama, Japan (http://www.insilicobiology.jp/en). A free fully functional trial version, as well as further information, is available on our homepage: http://www.genexplain.com/imc
  • 3. GenomeTraveler GenomeTraveler (GT) is a comprehensive software package for the analysis of whole genomes, which supports mapping of NGS fragments, mutation analysis, feature annotation and more. Key features of GenomeTraveler:  Mapping of single- and paired-end fragments  Contig mapping  de novo assembly  Import of mapping/assembling results from SAMtool, SOLiD, Velvet and Phrab  Profile peak detection  Mutation and SNP analysis  Expression analysis  The alignment viewer includes: search, annotation and comparative genome functions GenomeTraveler is a program for next generation sequencing data analysis and annotation. It can handle data from Roche/454 GS FLX, ABI SOLiD and Illumina GA, and provides a graphical interface for smooth viewing and editing of mapping and assembly results. The software runs on Windows, Mac and Linux and has been developed by in silico biology, Inc., in Yokohama, Japan (http://www.insilicobiology.jp/en). A free fully functional trial version, as well as further information, is available on our homepage: http://www.genexplain.com/genome-traveler
  • 4. PASS The acronym PASS stands for Prediction of Activity Spectra for Substances. After entering structural formulas of drug-like organic compounds - either a single structure or a big library - the program instantly gives a list of predicted bioactivities, accompanied by estimated mathematical probabilities. Key features of PASS:  Standard MOL and SDF files are used as input structural data  Multilevel Neighborhood of Atoms (MNA) descriptors are used to create robust and predictive SAR models  Activity spectra for thousands of compounds can be predicted within minutes  Impact of each atom on a particular activity is highlighted by its color  Currently, over 4,300 bioactivities can be predicted  Mathematical algorithm based on Bayesian estimates of probabilities PASS can quickly predict biological activity spectra for organic drug-like compounds qualitatively. The activities that can be predicted range from pharmacotherapeutic effects, biochemical mechanisms and toxic and adverse effects to influence on the metabolism, gene regulation and transporter-related activities. The software runs under Windows. Since more than 15 years, PASS is permanently being developed by Vladimir Poroikov, Dmitry Filimonov & Associates currently working in the Department for Bioinformatics at the Institute of Biomedical Chemistry, Russian Academy of Medical Sciences in Moscow (http://www.pharmaexpert.ru/PASSOnline/). A free demo version, as well as further information, is available on our website: http://www.genexplain.com/pass
  • 5. PharmaExpert PharmaExpert analyzes the relationships between biological activities, drug-drug interactions and the multiple targeting actions of chemical compounds. As a pharmacological knowledge-based tool, it provides in silico screening of compounds using PASS prediction results. Key features of PharmaExpert:  Mechanism-effect relationship (MER) base, manually curated by experts, containing 11,049 mechanism-effect relationships  Selection of compounds with required therapeutic but without side effects  Comparative analysis of compounds with similar structures  Selection of compounds with multiple mechanisms of action  Analysis of drug-drug interactions with regard to their pharmacokinetic, pharmacodynamic and adverse effects PharmaExpert uses PASS (Prediction of Activity Spectra for Substances) predictions as input information. It provides a comfortable solution for data mining of the PASS prediction results to find the best drug-like candidates from a set of compounds. The core of the program is a mechanism-effect relationship (MER) base, which is used to determine cause-effect relationships for the compounds. Like PASS, the software runs under Windows. Since more than 15 years, PharmaExpert is permanently being developed by Vladimir Poroikov, Dmitry Filimonov & Associates currently working in the Department for Bioinformatics at the Institute of Biomedical Chemistry, Russian Academy of Medical Sciences in Moscow (http://www.pharmaexpert.ru/PASSOnline/). A free demo version, as well as further information, is available on our homepage: http://www.genexplain.com/pharmaexpert
  • 6. About geneXplain GmbH GeneXplain GmbH has been founded in April 2010 and is based in Wolfenbüttel, Germany. The company aims at providing a comprehensive set of computational tools supporting the complete drug development pipeline from the statistical evaluation of high-throughput data, their biological interpretation, and identification of potential targets to the prediction of most promising lead structures. The geneXplain platform is based on BioUML and has been developed together with the Institute of Systems Biology, Novosibirsk, Russia, where this leading-edge technology originates. Your geneXplain team geneXplain GmbH Am Exer 10b D-38302 Wolfenbüttel Germany phone: +49-5331-9450434 e-mail: info@genexplain.com URL: http://www.genexplain.com Facebook: http://www.facebook.com/genexplain Twitter: https://twitter.com/#!/geneXplain LinkedIn: http://www.linkedin.com/company/genexplain Google+: https://plus.google.com/104816244332282237960